Clinical Trial Update: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

View source ↗

Summary

Clinical trial evaluating adherence to and patient acceptability of Zomacton administered with the Zomajet Vision X device was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Turner Syndrome

Drugs mentioned

• ZOMACTON (Somatropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Growth Hormone Deficiency, Turner's Syndrome | Status: TERMINATED